Skip to main content

Table 1 Demographic and clinical characteristics of the study population

From: Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis

  Training Set Validation Set P T-V
  MCD FSGS P MCD FSGS P MCD FSGS
No. of subjects 10 11   14 14    
Age (years) 39.5 (28.0 –68.0) 57.0 (31.0 –71.0) 0.57 55.5 (30.0 –72.0) 54.5 (36.0 –59.0) 0.45 0.32 0.85
Female/male ratio 3/7 5/6 0.47 6/8 2/12 0.09 0.52 0.08
Body mass index (kg/m2) 27.3 (21.9 –33.8) 25.5 (24.0 –26.6) 0.68 29.4 (24.2 –30.6) 26.3 (25.1 –28.4) 0.63 0.76 0.41
Body surface area 1.7 (1.7 –1. 9) 1.8 (1.6 –1.8) 0.83 1.8 (1.6 –1.9) 1.9 (1.8 –2.0) 0.35 0.52 0.11
Serum glucose (mg/dl) 91 (81–101) 88 (83–97) 0.89 84 (81–94) 94 (87–97) 0.19 0.44 0.67
Serum protein (g/dl) 4.4 (3.7 –4.7) 5.0 (4.1 –6.2) 0.09 4.7 (4.1 –4.9) 6.1 (4.5 –6.3) 0.05 0.29 0.56
Serum creatinine (mg/dl) 0.9 (0.8 –1.0) 1.2 (0.9 –1.2) 0.12 0.9 (0.8 –1.3) 1.3 (0.9 –1.8) 0.24 0.64 0.62
Proteinuria (g/24 h) 10.6 (2.3 –12.2) 3.5 (2.5 –7.4) 0.29 9.7 (5.9 –15.0) 3.4 (1.7 –4.5) 0.004 0.52 0.64
  1. Data are shown as median (interquartile range)
  2. Differences between groups were tested using the non-parametric Kruskall Wallis test. P T-V shows P value between training and validation set. P < 0.05 was considered significant